Table 6 |
||||||
|
WOMAC functional impairment scores by group and visit |
||||||
|
Group |
||||||
|
UP446 250 mg/day |
UP446 500 mg/day |
Celecoxib 200 mg/day |
Placebo |
|||
|
|
||||||
|
Visit |
Baseline |
Mean |
3.34 |
3.52 |
2.98 |
3.11 |
|
Std Deviation |
0.91 |
0.71 |
0.41 |
0.33 |
||
|
30 Days |
Mean |
2.68 |
2.90 |
2.94 |
3.08 |
|
|
Std Deviation |
0.58 |
0.69 |
0.37 |
0.59 |
||
|
60 Days |
Mean |
2.66 |
2.66 |
2.65 |
2.99 |
|
|
Std Deviation |
0.31 |
0.29 |
0.36 |
0.29 |
||
|
90 Days |
Mean |
2.70 |
2.52 |
2.78 |
3.04 |
|
|
Std Deviation |
0.68 |
0.53 |
0.44 |
0.51 |
||
|
|
||||||
|
Sampalis and Brownell Nutrition Journal 2012 11:21 doi:10.1186/1475-2891-11-21 |
||||||
